Anti-retroviral Drugs Market to hit USD 42.5 billion by 2032, says Global Market Insights Inc.
Anti-retroviral drugs industry is projected to witness a CAGR of 4.2% during the period 2024-2032. This growth can be attributed to increasing investment in research and development.
Selbyville, Delaware, Sept. 25, 2024 (GLOBE NEWSWIRE) —
Anti-retroviral Drugs
Anti-retroviral Drugs Market Players
Major players in the anti-retroviral drugs industry include AbbVie Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc., Merck & Co., Inc., Viatris Inc., Boehringer Ingelheim International GmbH, Cipla, Gilead Sciences, Inc., Johnson & Johnson, and Pfizer Inc., among others.
Companies are expanding their share by focusing on strategic initiatives such as mergers, acquisitions, and partnerships to enhance their product portfolios and global reach. Investments in research and development (R&D) are driving the introduction of innovative therapies with improved efficacy and reduced side effects. Additionally, these companies are expanding access to affordable treatment through collaborations with governments and non-profit organizations, particularly in low-income regions. Expanding their manufacturing capacities and distribution networks further strengthens their market position.
Partial Table of Contents (ToC) of the report:
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing investment in research and development
3.2.1.2 Growing burden of HIV
3.2.1.3 Increase in availability of novel drugs for treatment of HIV
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects associated with the drugs
3.2.2.2 High cost of the treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Browse more healthcare industry reports @ https://www.gminsights.com/industry-reports/healthcare
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
CONTACT: Contact Us: Aashit Tiwari Corporate Sales, USA Global Market Insights Inc. Toll Free: +1-888-689-0688 USA: +1-302-846-7766 Europe: +44-742-759-8484 APAC: +65-3129-7718 Email: [email protected] Read More News @ https://ibmag.com
